The latest Orbital newsletter
Alzheimers disease; Chiral complexes target amyloid β
Stereochemistry is a very important issue for pharmaceutical industry and can determine drug efficacy. Scott group metallohelices have been shown, in collaboration with Xiaogang Chu and co-workers at Changchun Institute of Applied Chemistry, China, to enantioselectively target and inhibit amyloid (Aβ) aggregation. This provides new insights into chiral inhibition of Aβ aggregation and opens a new avenue for design and screening of chiral agents as Aβ inhibitors against Alzheimer's disease. The work is published in J. Am. Chem. Soc.